The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global NSE ELISA Kits Market Research Report 2025
Synopsis
NSE ELISA Kits are enzyme-linked immunosorbent assay kits used for the quantitative measurement of Neuron-Specific Enolase (NSE). NSE is a neuroendocrine marker that is expressed in neuronal cells and is often used in the diagnosis and monitoring of brain tumors, neurodegenerative diseases, and other neurological disorders. The kits provide a convenient, precise, and reliable method for assessing NSE levels in biological samples such as serum, plasma, and cerebrospinal fluid.
The global NSE ELISA Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for NSE ELISA Kits reflects the increasing emphasis on precision medicine and personalized approaches to healthcare. With the development of advanced diagnostics and companion diagnostics, NSE ELISA Kits are becoming essential tools for monitoring disease progression and treatment response in neurological disorders. Furthermore, the trend includes the use of biologics and biopharmaceuticals, which offer a new class of therapeutic options for patients with rare and difficult-to-treat diseases.
Note: I have provided these definitions based on my general understanding of the market trends and product types, and they may not be completely accurate or up-to-date. You may want to consult with a professional in the field for more accurate information.
This report aims to provide a comprehensive presentation of the global market for NSE ELISA Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSE ELISA Kits.
Report Scope
The NSE ELISA Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NSE ELISA Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NSE ELISA Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MyBioSource
Abcam
CUSABIO Technology
Biorbyt
Antibodies
Eagle Bioscience
G Biosciences
ABclonal Technology
Biomatik
IBL
Bioss
Creative Diagnostics
United States Biological
BioVendor Laboratory Medicine
Wuhan Fine Biotech
DEMEDITEC Diagnostics GmbH
LSBio
XpressBio
Thermo Fisher Scientific
American Research Products Inc.
Rocky Mountain Diagnostics
Elabscience Bionovation
ELK Biotechnology
Krishgen Biosystems
Segment by Type
Human NSE ELISA Kits
Rat NSE ELISA Kits
Others
Segment by Application
Laboratory
Colleges
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NSE ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NSE ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
NSE ELISA Kits are enzyme-linked immunosorbent assay kits used for the quantitative measurement of Neuron-Specific Enolase (NSE). NSE is a neuroendocrine marker that is expressed in neuronal cells and is often used in the diagnosis and monitoring of brain tumors, neurodegenerative diseases, and other neurological disorders. The kits provide a convenient, precise, and reliable method for assessing NSE levels in biological samples such as serum, plasma, and cerebrospinal fluid.
The global NSE ELISA Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for NSE ELISA Kits reflects the increasing emphasis on precision medicine and personalized approaches to healthcare. With the development of advanced diagnostics and companion diagnostics, NSE ELISA Kits are becoming essential tools for monitoring disease progression and treatment response in neurological disorders. Furthermore, the trend includes the use of biologics and biopharmaceuticals, which offer a new class of therapeutic options for patients with rare and difficult-to-treat diseases.
Note: I have provided these definitions based on my general understanding of the market trends and product types, and they may not be completely accurate or up-to-date. You may want to consult with a professional in the field for more accurate information.
This report aims to provide a comprehensive presentation of the global market for NSE ELISA Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSE ELISA Kits.
Report Scope
The NSE ELISA Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NSE ELISA Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NSE ELISA Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MyBioSource
Abcam
CUSABIO Technology
Biorbyt
Antibodies
Eagle Bioscience
G Biosciences
ABclonal Technology
Biomatik
IBL
Bioss
Creative Diagnostics
United States Biological
BioVendor Laboratory Medicine
Wuhan Fine Biotech
DEMEDITEC Diagnostics GmbH
LSBio
XpressBio
Thermo Fisher Scientific
American Research Products Inc.
Rocky Mountain Diagnostics
Elabscience Bionovation
ELK Biotechnology
Krishgen Biosystems
Segment by Type
Human NSE ELISA Kits
Rat NSE ELISA Kits
Others
Segment by Application
Laboratory
Colleges
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NSE ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NSE ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 NSE ELISA Kits Market Overview
1.1 Product Overview and Scope of NSE ELISA Kits
1.2 NSE ELISA Kits Segment by Type
1.2.1 Global NSE ELISA Kits Market Value Comparison by Type (2024-2030)
1.2.2 Human NSE ELISA Kits
1.2.3 Rat NSE ELISA Kits
1.2.4 Others
1.3 NSE ELISA Kits Segment by Application
1.3.1 Global NSE ELISA Kits Market Value by Application: (2024-2030)
1.3.2 Laboratory
1.3.3 Colleges
1.3.4 Others
1.4 Global NSE ELISA Kits Market Size Estimates and Forecasts
1.4.1 Global NSE ELISA Kits Revenue 2019-2030
1.4.2 Global NSE ELISA Kits Sales 2019-2030
1.4.3 Global NSE ELISA Kits Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 NSE ELISA Kits Market Competition by Manufacturers
2.1 Global NSE ELISA Kits Sales Market Share by Manufacturers (2019-2024)
2.2 Global NSE ELISA Kits Revenue Market Share by Manufacturers (2019-2024)
2.3 Global NSE ELISA Kits Average Price by Manufacturers (2019-2024)
2.4 Global NSE ELISA Kits Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NSE ELISA Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NSE ELISA Kits, Product Type & Application
2.7 NSE ELISA Kits Market Competitive Situation and Trends
2.7.1 NSE ELISA Kits Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NSE ELISA Kits Players Market Share by Revenue
2.7.3 Global NSE ELISA Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NSE ELISA Kits Retrospective Market Scenario by Region
3.1 Global NSE ELISA Kits Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global NSE ELISA Kits Global NSE ELISA Kits Sales by Region: 2019-2030
3.2.1 Global NSE ELISA Kits Sales by Region: 2019-2024
3.2.2 Global NSE ELISA Kits Sales by Region: 2025-2030
3.3 Global NSE ELISA Kits Global NSE ELISA Kits Revenue by Region: 2019-2030
3.3.1 Global NSE ELISA Kits Revenue by Region: 2019-2024
3.3.2 Global NSE ELISA Kits Revenue by Region: 2025-2030
3.4 North America NSE ELISA Kits Market Facts & Figures by Country
3.4.1 North America NSE ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America NSE ELISA Kits Sales by Country (2019-2030)
3.4.3 North America NSE ELISA Kits Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe NSE ELISA Kits Market Facts & Figures by Country
3.5.1 Europe NSE ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe NSE ELISA Kits Sales by Country (2019-2030)
3.5.3 Europe NSE ELISA Kits Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific NSE ELISA Kits Market Facts & Figures by Country
3.6.1 Asia Pacific NSE ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific NSE ELISA Kits Sales by Country (2019-2030)
3.6.3 Asia Pacific NSE ELISA Kits Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America NSE ELISA Kits Market Facts & Figures by Country
3.7.1 Latin America NSE ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America NSE ELISA Kits Sales by Country (2019-2030)
3.7.3 Latin America NSE ELISA Kits Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa NSE ELISA Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa NSE ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa NSE ELISA Kits Sales by Country (2019-2030)
3.8.3 Middle East and Africa NSE ELISA Kits Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NSE ELISA Kits Sales by Type (2019-2030)
4.1.1 Global NSE ELISA Kits Sales by Type (2019-2024)
4.1.2 Global NSE ELISA Kits Sales by Type (2025-2030)
4.1.3 Global NSE ELISA Kits Sales Market Share by Type (2019-2030)
4.2 Global NSE ELISA Kits Revenue by Type (2019-2030)
4.2.1 Global NSE ELISA Kits Revenue by Type (2019-2024)
4.2.2 Global NSE ELISA Kits Revenue by Type (2025-2030)
4.2.3 Global NSE ELISA Kits Revenue Market Share by Type (2019-2030)
4.3 Global NSE ELISA Kits Price by Type (2019-2030)
5 Segment by Application
5.1 Global NSE ELISA Kits Sales by Application (2019-2030)
5.1.1 Global NSE ELISA Kits Sales by Application (2019-2024)
5.1.2 Global NSE ELISA Kits Sales by Application (2025-2030)
5.1.3 Global NSE ELISA Kits Sales Market Share by Application (2019-2030)
5.2 Global NSE ELISA Kits Revenue by Application (2019-2030)
5.2.1 Global NSE ELISA Kits Revenue by Application (2019-2024)
5.2.2 Global NSE ELISA Kits Revenue by Application (2025-2030)
5.2.3 Global NSE ELISA Kits Revenue Market Share by Application (2019-2030)
5.3 Global NSE ELISA Kits Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MyBioSource
6.1.1 MyBioSource Corporation Information
6.1.2 MyBioSource Description and Business Overview
6.1.3 MyBioSource NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MyBioSource NSE ELISA Kits Product Portfolio
6.1.5 MyBioSource Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Corporation Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abcam NSE ELISA Kits Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 CUSABIO Technology
6.3.1 CUSABIO Technology Corporation Information
6.3.2 CUSABIO Technology Description and Business Overview
6.3.3 CUSABIO Technology NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CUSABIO Technology NSE ELISA Kits Product Portfolio
6.3.5 CUSABIO Technology Recent Developments/Updates
6.4 Biorbyt
6.4.1 Biorbyt Corporation Information
6.4.2 Biorbyt Description and Business Overview
6.4.3 Biorbyt NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biorbyt NSE ELISA Kits Product Portfolio
6.4.5 Biorbyt Recent Developments/Updates
6.5 Antibodies
6.5.1 Antibodies Corporation Information
6.5.2 Antibodies Description and Business Overview
6.5.3 Antibodies NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Antibodies NSE ELISA Kits Product Portfolio
6.5.5 Antibodies Recent Developments/Updates
6.6 Eagle Bioscience
6.6.1 Eagle Bioscience Corporation Information
6.6.2 Eagle Bioscience Description and Business Overview
6.6.3 Eagle Bioscience NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eagle Bioscience NSE ELISA Kits Product Portfolio
6.6.5 Eagle Bioscience Recent Developments/Updates
6.7 G Biosciences
6.6.1 G Biosciences Corporation Information
6.6.2 G Biosciences Description and Business Overview
6.6.3 G Biosciences NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.4.4 G Biosciences NSE ELISA Kits Product Portfolio
6.7.5 G Biosciences Recent Developments/Updates
6.8 ABclonal Technology
6.8.1 ABclonal Technology Corporation Information
6.8.2 ABclonal Technology Description and Business Overview
6.8.3 ABclonal Technology NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ABclonal Technology NSE ELISA Kits Product Portfolio
6.8.5 ABclonal Technology Recent Developments/Updates
6.9 Biomatik
6.9.1 Biomatik Corporation Information
6.9.2 Biomatik Description and Business Overview
6.9.3 Biomatik NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biomatik NSE ELISA Kits Product Portfolio
6.9.5 Biomatik Recent Developments/Updates
6.10 IBL
6.10.1 IBL Corporation Information
6.10.2 IBL Description and Business Overview
6.10.3 IBL NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.10.4 IBL NSE ELISA Kits Product Portfolio
6.10.5 IBL Recent Developments/Updates
6.11 Bioss
6.11.1 Bioss Corporation Information
6.11.2 Bioss NSE ELISA Kits Description and Business Overview
6.11.3 Bioss NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bioss NSE ELISA Kits Product Portfolio
6.11.5 Bioss Recent Developments/Updates
6.12 Creative Diagnostics
6.12.1 Creative Diagnostics Corporation Information
6.12.2 Creative Diagnostics NSE ELISA Kits Description and Business Overview
6.12.3 Creative Diagnostics NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Creative Diagnostics NSE ELISA Kits Product Portfolio
6.12.5 Creative Diagnostics Recent Developments/Updates
6.13 United States Biological
6.13.1 United States Biological Corporation Information
6.13.2 United States Biological NSE ELISA Kits Description and Business Overview
6.13.3 United States Biological NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.13.4 United States Biological NSE ELISA Kits Product Portfolio
6.13.5 United States Biological Recent Developments/Updates
6.14 BioVendor Laboratory Medicine
6.14.1 BioVendor Laboratory Medicine Corporation Information
6.14.2 BioVendor Laboratory Medicine NSE ELISA Kits Description and Business Overview
6.14.3 BioVendor Laboratory Medicine NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.14.4 BioVendor Laboratory Medicine NSE ELISA Kits Product Portfolio
6.14.5 BioVendor Laboratory Medicine Recent Developments/Updates
6.15 Wuhan Fine Biotech
6.15.1 Wuhan Fine Biotech Corporation Information
6.15.2 Wuhan Fine Biotech NSE ELISA Kits Description and Business Overview
6.15.3 Wuhan Fine Biotech NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Wuhan Fine Biotech NSE ELISA Kits Product Portfolio
6.15.5 Wuhan Fine Biotech Recent Developments/Updates
6.16 DEMEDITEC Diagnostics GmbH
6.16.1 DEMEDITEC Diagnostics GmbH Corporation Information
6.16.2 DEMEDITEC Diagnostics GmbH NSE ELISA Kits Description and Business Overview
6.16.3 DEMEDITEC Diagnostics GmbH NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.16.4 DEMEDITEC Diagnostics GmbH NSE ELISA Kits Product Portfolio
6.16.5 DEMEDITEC Diagnostics GmbH Recent Developments/Updates
6.17 LSBio
6.17.1 LSBio Corporation Information
6.17.2 LSBio NSE ELISA Kits Description and Business Overview
6.17.3 LSBio NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.17.4 LSBio NSE ELISA Kits Product Portfolio
6.17.5 LSBio Recent Developments/Updates
6.18 XpressBio
6.18.1 XpressBio Corporation Information
6.18.2 XpressBio NSE ELISA Kits Description and Business Overview
6.18.3 XpressBio NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.18.4 XpressBio NSE ELISA Kits Product Portfolio
6.18.5 XpressBio Recent Developments/Updates
6.19 Thermo Fisher Scientific
6.19.1 Thermo Fisher Scientific Corporation Information
6.19.2 Thermo Fisher Scientific NSE ELISA Kits Description and Business Overview
6.19.3 Thermo Fisher Scientific NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Thermo Fisher Scientific NSE ELISA Kits Product Portfolio
6.19.5 Thermo Fisher Scientific Recent Developments/Updates
6.20 American Research Products Inc.
6.20.1 American Research Products Inc. Corporation Information
6.20.2 American Research Products Inc. NSE ELISA Kits Description and Business Overview
6.20.3 American Research Products Inc. NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.20.4 American Research Products Inc. NSE ELISA Kits Product Portfolio
6.20.5 American Research Products Inc. Recent Developments/Updates
6.21 Rocky Mountain Diagnostics
6.21.1 Rocky Mountain Diagnostics Corporation Information
6.21.2 Rocky Mountain Diagnostics NSE ELISA Kits Description and Business Overview
6.21.3 Rocky Mountain Diagnostics NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Rocky Mountain Diagnostics NSE ELISA Kits Product Portfolio
6.21.5 Rocky Mountain Diagnostics Recent Developments/Updates
6.22 Elabscience Bionovation
6.22.1 Elabscience Bionovation Corporation Information
6.22.2 Elabscience Bionovation NSE ELISA Kits Description and Business Overview
6.22.3 Elabscience Bionovation NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Elabscience Bionovation NSE ELISA Kits Product Portfolio
6.22.5 Elabscience Bionovation Recent Developments/Updates
6.23 ELK Biotechnology
6.23.1 ELK Biotechnology Corporation Information
6.23.2 ELK Biotechnology NSE ELISA Kits Description and Business Overview
6.23.3 ELK Biotechnology NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.23.4 ELK Biotechnology NSE ELISA Kits Product Portfolio
6.23.5 ELK Biotechnology Recent Developments/Updates
6.24 Krishgen Biosystems
6.24.1 Krishgen Biosystems Corporation Information
6.24.2 Krishgen Biosystems NSE ELISA Kits Description and Business Overview
6.24.3 Krishgen Biosystems NSE ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Krishgen Biosystems NSE ELISA Kits Product Portfolio
6.24.5 Krishgen Biosystems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NSE ELISA Kits Industry Chain Analysis
7.2 NSE ELISA Kits Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NSE ELISA Kits Production Mode & Process
7.4 NSE ELISA Kits Sales and Marketing
7.4.1 NSE ELISA Kits Sales Channels
7.4.2 NSE ELISA Kits Distributors
7.5 NSE ELISA Kits Customers
8 NSE ELISA Kits Market Dynamics
8.1 NSE ELISA Kits Industry Trends
8.2 NSE ELISA Kits Market Drivers
8.3 NSE ELISA Kits Market Challenges
8.4 NSE ELISA Kits Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global NSE ELISA Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global NSE ELISA Kits Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global NSE ELISA Kits Market Competitive Situation by Manufacturers in 2023
Table 4. Global NSE ELISA Kits Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global NSE ELISA Kits Sales Market Share by Manufacturers (2019-2024)
Table 6. Global NSE ELISA Kits Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global NSE ELISA Kits Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market NSE ELISA Kits Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of NSE ELISA Kits, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of NSE ELISA Kits, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of NSE ELISA Kits, Product Type & Application
Table 12. Global Key Manufacturers of NSE ELISA Kits, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global NSE ELISA Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSE ELISA Kits as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global NSE ELISA Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global NSE ELISA Kits Sales by Region (2019-2024) & (K Units)
Table 18. Global NSE ELISA Kits Sales Market Share by Region (2019-2024)
Table 19. Global NSE ELISA Kits Sales by Region (2025-2030) & (K Units)
Table 20. Global NSE ELISA Kits Sales Market Share by Region (2025-2030)
Table 21. Global NSE ELISA Kits Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global NSE ELISA Kits Revenue Market Share by Region (2019-2024)
Table 23. Global NSE ELISA Kits Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global NSE ELISA Kits Revenue Market Share by Region (2025-2030)
Table 25. North America NSE ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America NSE ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 27. North America NSE ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 28. North America NSE ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America NSE ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe NSE ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe NSE ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 32. Europe NSE ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 33. Europe NSE ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe NSE ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific NSE ELISA Kits Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific NSE ELISA Kits Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific NSE ELISA Kits Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific NSE ELISA Kits Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific NSE ELISA Kits Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America NSE ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America NSE ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 42. Latin America NSE ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 43. Latin America NSE ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America NSE ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa NSE ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa NSE ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa NSE ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa NSE ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa NSE ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global NSE ELISA Kits Sales (K Units) by Type (2019-2024)
Table 51. Global NSE ELISA Kits Sales (K Units) by Type (2025-2030)
Table 52. Global NSE ELISA Kits Sales Market Share by Type (2019-2024)
Table 53. Global NSE ELISA Kits Sales Market Share by Type (2025-2030)
Table 54. Global NSE ELISA Kits Revenue (US$ Million) by Type (2019-2024)
Table 55. Global NSE ELISA Kits Revenue (US$ Million) by Type (2025-2030)
Table 56. Global NSE ELISA Kits Revenue Market Share by Type (2019-2024)
Table 57. Global NSE ELISA Kits Revenue Market Share by Type (2025-2030)
Table 58. Global NSE ELISA Kits Price (US$/Unit) by Type (2019-2024)
Table 59. Global NSE ELISA Kits Price (US$/Unit) by Type (2025-2030)
Table 60. Global NSE ELISA Kits Sales (K Units) by Application (2019-2024)
Table 61. Global NSE ELISA Kits Sales (K Units) by Application (2025-2030)
Table 62. Global NSE ELISA Kits Sales Market Share by Application (2019-2024)
Table 63. Global NSE ELISA Kits Sales Market Share by Application (2025-2030)
Table 64. Global NSE ELISA Kits Revenue (US$ Million) by Application (2019-2024)
Table 65. Global NSE ELISA Kits Revenue (US$ Million) by Application (2025-2030)
Table 66. Global NSE ELISA Kits Revenue Market Share by Application (2019-2024)
Table 67. Global NSE ELISA Kits Revenue Market Share by Application (2025-2030)
Table 68. Global NSE ELISA Kits Price (US$/Unit) by Application (2019-2024)
Table 69. Global NSE ELISA Kits Price (US$/Unit) by Application (2025-2030)
Table 70. MyBioSource Corporation Information
Table 71. MyBioSource Description and Business Overview
Table 72. MyBioSource NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. MyBioSource NSE ELISA Kits Product
Table 74. MyBioSource Recent Developments/Updates
Table 75. Abcam Corporation Information
Table 76. Abcam Description and Business Overview
Table 77. Abcam NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Abcam NSE ELISA Kits Product
Table 79. Abcam Recent Developments/Updates
Table 80. CUSABIO Technology Corporation Information
Table 81. CUSABIO Technology Description and Business Overview
Table 82. CUSABIO Technology NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. CUSABIO Technology NSE ELISA Kits Product
Table 84. CUSABIO Technology Recent Developments/Updates
Table 85. Biorbyt Corporation Information
Table 86. Biorbyt Description and Business Overview
Table 87. Biorbyt NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Biorbyt NSE ELISA Kits Product
Table 89. Biorbyt Recent Developments/Updates
Table 90. Antibodies Corporation Information
Table 91. Antibodies Description and Business Overview
Table 92. Antibodies NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Antibodies NSE ELISA Kits Product
Table 94. Antibodies Recent Developments/Updates
Table 95. Eagle Bioscience Corporation Information
Table 96. Eagle Bioscience Description and Business Overview
Table 97. Eagle Bioscience NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Eagle Bioscience NSE ELISA Kits Product
Table 99. Eagle Bioscience Recent Developments/Updates
Table 100. G Biosciences Corporation Information
Table 101. G Biosciences Description and Business Overview
Table 102. G Biosciences NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. G Biosciences NSE ELISA Kits Product
Table 104. G Biosciences Recent Developments/Updates
Table 105. ABclonal Technology Corporation Information
Table 106. ABclonal Technology Description and Business Overview
Table 107. ABclonal Technology NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. ABclonal Technology NSE ELISA Kits Product
Table 109. ABclonal Technology Recent Developments/Updates
Table 110. Biomatik Corporation Information
Table 111. Biomatik Description and Business Overview
Table 112. Biomatik NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biomatik NSE ELISA Kits Product
Table 114. Biomatik Recent Developments/Updates
Table 115. IBL Corporation Information
Table 116. IBL Description and Business Overview
Table 117. IBL NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. IBL NSE ELISA Kits Product
Table 119. IBL Recent Developments/Updates
Table 120. Bioss Corporation Information
Table 121. Bioss Description and Business Overview
Table 122. Bioss NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Bioss NSE ELISA Kits Product
Table 124. Bioss Recent Developments/Updates
Table 125. Creative Diagnostics Corporation Information
Table 126. Creative Diagnostics Description and Business Overview
Table 127. Creative Diagnostics NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Creative Diagnostics NSE ELISA Kits Product
Table 129. Creative Diagnostics Recent Developments/Updates
Table 130. United States Biological Corporation Information
Table 131. United States Biological Description and Business Overview
Table 132. United States Biological NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. United States Biological NSE ELISA Kits Product
Table 134. United States Biological Recent Developments/Updates
Table 135. BioVendor Laboratory Medicine Corporation Information
Table 136. BioVendor Laboratory Medicine Description and Business Overview
Table 137. BioVendor Laboratory Medicine NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. BioVendor Laboratory Medicine NSE ELISA Kits Product
Table 139. BioVendor Laboratory Medicine Recent Developments/Updates
Table 140. Wuhan Fine Biotech Corporation Information
Table 141. Wuhan Fine Biotech Description and Business Overview
Table 142. Wuhan Fine Biotech NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Wuhan Fine Biotech NSE ELISA Kits Product
Table 144. Wuhan Fine Biotech Recent Developments/Updates
Table 145. DEMEDITEC Diagnostics GmbH Corporation Information
Table 146. DEMEDITEC Diagnostics GmbH Description and Business Overview
Table 147. DEMEDITEC Diagnostics GmbH NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. DEMEDITEC Diagnostics GmbH NSE ELISA Kits Product
Table 149. DEMEDITEC Diagnostics GmbH Recent Developments/Updates
Table 150. LSBio Corporation Information
Table 151. LSBio Description and Business Overview
Table 152. LSBio NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. LSBio NSE ELISA Kits Product
Table 154. LSBio Recent Developments/Updates
Table 155. XpressBio Corporation Information
Table 156. XpressBio Description and Business Overview
Table 157. XpressBio NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. XpressBio NSE ELISA Kits Product
Table 159. XpressBio Recent Developments/Updates
Table 160. Thermo Fisher Scientific Corporation Information
Table 161. Thermo Fisher Scientific Description and Business Overview
Table 162. Thermo Fisher Scientific NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Thermo Fisher Scientific NSE ELISA Kits Product
Table 164. Thermo Fisher Scientific Recent Developments/Updates
Table 165. American Research Products Inc. Corporation Information
Table 166. American Research Products Inc. Description and Business Overview
Table 167. American Research Products Inc. NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. American Research Products Inc. NSE ELISA Kits Product
Table 169. American Research Products Inc. Recent Developments/Updates
Table 170. Rocky Mountain Diagnostics Corporation Information
Table 171. Rocky Mountain Diagnostics Description and Business Overview
Table 172. Rocky Mountain Diagnostics NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Rocky Mountain Diagnostics NSE ELISA Kits Product
Table 174. Rocky Mountain Diagnostics Recent Developments/Updates
Table 175. Elabscience Bionovation Corporation Information
Table 176. Elabscience Bionovation Description and Business Overview
Table 177. Elabscience Bionovation NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Elabscience Bionovation NSE ELISA Kits Product
Table 179. Elabscience Bionovation Recent Developments/Updates
Table 180. ELK Biotechnology Corporation Information
Table 181. ELK Biotechnology Description and Business Overview
Table 182. ELK Biotechnology NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. ELK Biotechnology NSE ELISA Kits Product
Table 184. ELK Biotechnology Recent Developments/Updates
Table 185. Krishgen Biosystems Corporation Information
Table 186. Krishgen Biosystems Description and Business Overview
Table 187. Krishgen Biosystems NSE ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Krishgen Biosystems NSE ELISA Kits Product
Table 189. Krishgen Biosystems Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. NSE ELISA Kits Distributors List
Table 193. NSE ELISA Kits Customers List
Table 194. NSE ELISA Kits Market Trends
Table 195. NSE ELISA Kits Market Drivers
Table 196. NSE ELISA Kits Market Challenges
Table 197. NSE ELISA Kits Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of NSE ELISA Kits
Figure 2. Global NSE ELISA Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global NSE ELISA Kits Market Share by Type in 2023 & 2030
Figure 4. Human NSE ELISA Kits Product Picture
Figure 5. Rat NSE ELISA Kits Product Picture
Figure 6. Others Product Picture
Figure 7. Global NSE ELISA Kits Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global NSE ELISA Kits Market Share by Application in 2023 & 2030
Figure 9. Laboratory
Figure 10. Colleges
Figure 11. Others
Figure 12. Global NSE ELISA Kits Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global NSE ELISA Kits Market Size (2019-2030) & (US$ Million)
Figure 14. Global NSE ELISA Kits Sales (2019-2030) & (K Units)
Figure 15. Global NSE ELISA Kits Average Price (US$/Unit) & (2019-2030)
Figure 16. NSE ELISA Kits Report Years Considered
Figure 17. NSE ELISA Kits Sales Share by Manufacturers in 2023
Figure 18. Global NSE ELISA Kits Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest NSE ELISA Kits Players: Market Share by Revenue in 2023
Figure 20. NSE ELISA Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global NSE ELISA Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America NSE ELISA Kits Sales Market Share by Country (2019-2030)
Figure 23. North America NSE ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 24. United States NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe NSE ELISA Kits Sales Market Share by Country (2019-2030)
Figure 27. Europe NSE ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 28. Germany NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific NSE ELISA Kits Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific NSE ELISA Kits Revenue Market Share by Region (2019-2030)
Figure 35. China NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America NSE ELISA Kits Sales Market Share by Country (2019-2030)
Figure 43. Latin America NSE ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 44. Mexico NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa NSE ELISA Kits Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa NSE ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 49. Turkey NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE NSE ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of NSE ELISA Kits by Type (2019-2030)
Figure 53. Global Revenue Market Share of NSE ELISA Kits by Type (2019-2030)
Figure 54. Global NSE ELISA Kits Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of NSE ELISA Kits by Application (2019-2030)
Figure 56. Global Revenue Market Share of NSE ELISA Kits by Application (2019-2030)
Figure 57. Global NSE ELISA Kits Price (US$/Unit) by Application (2019-2030)
Figure 58. NSE ELISA Kits Value Chain
Figure 59. NSE ELISA Kits Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
